Inhaled Adenovirus-Vectored SARS-CoV-2 Vaccine (AZD1222/ChAdOx1-nCov-19) Induces Long-Lasting, Polyfunctional T Cell Responses in Human Blood and Lung: A Single-Centre, Open-Label, Phase I Clinical Trial

Read full text Summarise with VIRAT
Authors: Nana‐Marie Lemm, Helen R. Wagstaffe, Stephanie Ascough, Rosanna Chappell Elkin, Negin Bayat, Lucy Danso, Osman Hatem, Mirae Park, Polly Fox, Orlagh Daly, Lydia Slater, Richard McKendry
+20 more Loukas Papargyris, Ashley M. Collins, Joanne McKenzie, Jiayun Xu, Pete Dayananda, Jon Guy, Henna Siddiqui, Federica Cappuccini, Leila Godfrey, Reece Mabbett, Xueheng Wang, Alistair Devine, Natalie ST Man, Meg Coleman, Lydia Finney, Sarah C. Gilbert, Onn Min Kon, Teresa Lambe, Katrina M. Pollock, Christopher Chiu
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies Immune responses and vaccinations

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Language
EN
Document type
Preprint